AstraZeneca reports Phase III results for Ultomiris and Sone-Ve
AstraZeneca has released findings from two Phase III studies of Ultomiris (ravulizumab) in thrombotic microangiopathy following haematopoietic stem…
AstraZeneca reports Phase III results for Ultomiris and Sone-Ve
AstraZeneca has released findings from two Phase III studies of Ultomiris (ravulizumab) in thrombotic microangiopathy following haematopoietic stem…
Astrazeneca Q2 Earnings Call Highlights
Key Points Interested in Astrazeneca Plc? Here are five stocks we like better. Solid first-half performance: AstraZeneca reported…
GSK’s partner Hansoh Pharma succeeds in Chinese Phase III SCLC ADC trial
GSK’s bet on Hansoh Pharmaceutical’s antibody-drug conjugate (ADC) seems to be paying off as the drug met all…
AstraZeneca (AZN) Advances Oral GLP-1 Receptor Agonist Elecoglipron to Phase III Trials
AstraZeneca (NYSE:AZN) is one of the 12 Best Growth Stocks Trading in Oversold Territory. On June 8, AstraZeneca’s…
AstraZeneca (AZN) Advances Oral GLP-1 Receptor Agonist Elecoglipron to Phase III Trials
AstraZeneca (NYSE:AZN) is one of the 12 Best Growth Stocks Trading in Oversold Territory. On June 8, AstraZeneca’s…